Table 1.

Baseline Demographic and Clinical Characteristics of Human Immunodeficiency Virus–Infected Women Naive to Highly Active Antiretroviral Treatment

Characteristic	HIV-Infected Women, No. (%)a (N = 586)
Age, median (range), y	37 (17–67)
Race/ethnicity
White, non-Hispanic	99 (17)
Black, non-Hispanic	342 (58)
Hispanic	145 (25)
HIV transmission risk factor
Injection drug use	263 (45)
Heterosexual contact	207 (35)
Transfusion	22 (4)
Not identified	90 (15)
Data missing	4 (1)
CD4 T-cell count, cells/μL
≤200	93 (16)
201–350	142 (24)
351–500	143 (24)
>500	202 (34)
Median (range)	405 (2–1972)c
Data missing	6 (1)
CD8 T-cell count
≤580/ μ L	93 (16)
581–820/ μ L	164 (28)
821–1140/ μ L	167 (28)
>1140/ μ L	154 (26)
CD8 T-cell count, median (range), cells/ μ L	875 (91–3866)
CD8 T-cell data missing	8 (1.4)
HIV load, median (range), copies/mL	15 050 (48–1 800 000)b
Antiretroviral therapy
No therapy	372 (63)
Monotherapy	164 (28)
Combination therapy	50 (9)
HAART	0
HCV status
HCV negative	229 (39)
HCV positive (nonviremic)	64 (11)
HCV positive (viremic)	293 (50)
Ever had AIDS
Yes	51 (9)
No	535 (91)

Abbreviations: HAART, highly active antiretroviral therapy; HCV, hepatitis C virus; HIV, human immunodeficiency virus.

^aData represent no. (%) of women unless otherwise specified.

^bAmong 584 women with baseline HIV load data.

^cAmong 580 women with baseline CD4 T-cell data.